Carvedilol as an Adjunct to Endoscopic Cyanoacrylate Injection for Secondary Prophylaxis of Gastric Variceal Bleeding
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
Gastric variceal obturation is the current endoscopic therapy of choice for gastric variceal
bleeding but is associated with a high rebleeding rate. Carvedilol is a potent non-selective
β-blocker. The role of carvedilol in the prevention of recurrent gastric variceal bleeding is
not studied. This study aimed at evaluating the efficacy of carvedilol as an adjunct to
gastric variceal obturation in the secondary prophylaxis of gastric variceal bleeding.